Developing World Bioethics 15 (2):85-97 (2015)

Abstract
The principle of providing post-trial access for research participants to successful products of that research is widely accepted and has been enshrined in various declarations and guidelines. While recent ethical guidelines recognise that the responsibility to provide post-trial access extends to sponsors, regulators and government bodies as well as to researchers, it is the researchers who have the direct duty of care to participants. Researchers may thus need to act as advocates for trial participants, especially where government bodies, sponsors, and regulatory bodies have complex interests vested in decisions about whether or not new interventions are made available, how, and to whom. This paper provides an empirical account of post-trial access in the context of HIV prevention research. It describes both access to the successful products of research and the provision antiretroviral drugs for trial participants who acquire HIV. First, we provide evidence that, in the current system, there is considerable variation in the duration and timeliness of access. We then argue that by analysing the difficulties faced by researchers to this point, and their efforts to meet this obligation, much can be learned about how to secure post-trial access in HIV biomedical preventions trials. While researchers alone have a limited obligation, their advocacy on behalf of trial participants may be necessary to call the other parties to account
Keywords antiretroviral therapy  HIV/AIDS  empirical ethics  research ethics  distributive justice
Categories (categorize this paper)
DOI 10.1111/dewb.12039
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 70,079
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

Ethical Challenges in HIV Microbicide Research: What Protections Do Women Need?Ruth Macklin - 2011 - International Journal of Feminist Approaches to Bioethics 4 (2):124-143.

View all 6 references / Add more references

Citations of this work BETA

“Reasonable Availability” Criterion Remains Salient.Bridget Gabrielle Haire - 2016 - American Journal of Bioethics 16 (6):19-21.

Add more citations

Similar books and articles

Analytics

Added to PP index
2013-11-09

Total views
19 ( #581,966 of 2,506,053 )

Recent downloads (6 months)
1 ( #416,828 of 2,506,053 )

How can I increase my downloads?

Downloads

My notes